Sign Up to like & get
recommendations!
1
Published in 2018 at "Hematological Oncology"
DOI: 10.1002/hon.2559
Abstract: The international staging system (ISS) is the most commonly used risk‐stratification system for patients with multiple myeloma (MM) and is determined by serum albumin and β2‐microglobulin levels. In the two determinants, β2‐microglobulin levels are frequently…
read more here.
Keywords:
system;
myeloma;
international staging;
stage ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2021 at "British Journal of Haematology"
DOI: 10.1111/bjh.17118
Abstract: The Revised International Staging System (R‐ISS) stratifies patients affected by Multiple Myeloma (MM) into three distinct risk groups: R‐ISS I [ISS Stage I, Standard‐Risk cytogenetics and normal Lactase DeHydrogenase (LDH)], R‐ISS III (ISS stage III…
read more here.
Keywords:
risk;
detection;
staging system;
system iss ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18536
Abstract: To evaluate the performance of the second revision of the International Staging System 2 (R2ISS) in a realworld cohort, we applied the scoring system to patients with newlydiagnosed multiple myeloma (NDMM) in the Myeloma and…
read more here.
Keywords:
system;
survival;
myeloma;
group ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.8544
Abstract: 8544Background: ISS stage which underlies prognostic models used in MM, is derived from albumin and β2M at diagnosis. β2M, a low molecular polypeptide, is present on all nucleated cells and is elev...
read more here.
Keywords:
significance beta;
beta microglobulin;
microglobulin international;
staging system ... See more keywords